To prohibit pharmacy benefit managers and pharmacies from being under common ownership, and for other purposes.

Referred to the House Committee on the Judiciary.

2026-05-13

The legislation would prevent pharmacy benefit managers (companies that manage prescription drug benefits for insurance plans) and pharmacies from being owned by the same parent company. This change aims to reduce conflicts of interest where these companies could favor their own pharmacies over competitors or manipulate drug prices to benefit themselves, ultimately affecting patients' access to affordable medications and pharmacists' ability to compete fairly.